Literature DB >> 10597249

Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes.

M Nesbit1, H K Nesbit, J Bennett, T Andl, M Y Hsu, E Dejesus, M McBrian, A R Gupta, S L Eck, M Herlyn.   

Abstract

Basic fibroblast growth factor (bFGF or FGF-2) is produced by nearly all melanomas in vitro and in vivo but not by normal melanocytes, which require exogenous bFGF for growth. In this study, we transduced normal human melanocytes to overexpress two forms of bFGF: (bFGF-Long and bFGF-Short) using replication-deficient adenovirus 5 vectors. bFGF-Long induced the 17.8, 22.5, 23.1 and 24.2 kDa forms of bFGF, whereas bFGF-Short induced only the 17.8 kDa mature form. Growth of cultured melanocytes transduced with either vector was similar to that of nevus and melanoma cells and was independent of exogenous bFGF and of insulin/insulin-like growth factor 1, and cyclic AMP enhancers, requiring only phorbol ester as an exogenous mitogen. Like primary melanoma cells, transduced normal melanocytes grew anchorage independently in soft agar. When injected into the dermis of human skin grafted to mice, bFGF-transduced melanocytes proliferated for at least 20 days, whereas cells from control cultures showed poor survival and no proliferation. These results demonstrate that bFGF upregulation is a critical component in melanoma progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597249     DOI: 10.1038/sj.onc.1203066

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.

Authors:  Thomas Metzner; Alexandra Bedeir; Gerlinde Held; Barbara Peter-Vörösmarty; Sara Ghassemi; Christine Heinzle; Sabine Spiegl-Kreinecker; Brigitte Marian; Klaus Holzmann; Bettina Grasl-Kraupp; Christine Pirker; Michael Micksche; Walter Berger; Petra Heffeter; Michael Grusch
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

2.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  FGF2 Stimulates the Growth and Improves the Melanocytic Commitment of Trunk Neural Crest Cells.

Authors:  Bianca Luise Teixeira; Diego Amarante-Silva; Silvia Beatriz Visoni; Ricardo Castilho Garcez; Andrea Gonçalves Trentin
Journal:  Cell Mol Neurobiol       Date:  2019-09-25       Impact factor: 5.046

4.  A novel FGF2 antagonist peptide P8 with potent antiproliferation activity.

Authors:  Lei Fan; Hang Xie; Lingzi Chen; Hui Ye; Shilong Ying; Cong Wang; Xiaoping Wu; Wulan Li; Jianzhang Wu; Guang Liang; Xiaokun Li
Journal:  Tumour Biol       Date:  2014-07-26

5.  ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602).

Authors:  Ronald S Go; Sandra J Lee; Donghoon Shin; Steven M Callister; Dean A Jobe; Robert M Conry; Ahmad A Tarhini; John M Kirkwood
Journal:  Clin Cancer Res       Date:  2013-10-11       Impact factor: 12.531

6.  Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.

Authors:  Zhao-Jun Liu; Takashi Shirakawa; Yan Li; Akinobu Soma; Masahiro Oka; G Paolo Dotto; Ronald M Fairman; Omaida C Velazquez; Meenhard Herlyn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

7.  Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

Authors:  Kerrington R Molhoek; Amber L Shada; Mark Smolkin; Sudhir Chowbina; Jason Papin; David L Brautigan; Craig L Slingluff
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

8.  Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.

Authors:  C Berking; R Takemoto; K Satyamoorthy; R Elenitsas; M Herlyn
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

9.  Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.

Authors:  Michael G Gartside; Huaibin Chen; Omar A Ibrahimi; Sara A Byron; Amy V Curtis; Candice L Wellens; Ana Bengston; Laura M Yudt; Anna V Eliseenkova; Jinghong Ma; John A Curtin; Pilar Hyder; Ursula L Harper; Erica Riedesel; Graham J Mann; Jeffrey M Trent; Boris C Bastian; Paul S Meltzer; Moosa Mohammadi; Pamela M Pollock
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death.

Authors:  Cheryl J A Hirst; Meenhard Herlyn; Peter A Cattini; Elissavet Kardami
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.